Frontlight ResearchEarly access
CompletedNo phase
Intra-articular Administration of Med Device Made of Biological Vegetal Matrix for the Treatment of Knee Osteoarthritis
Key facts
- Who runs it
- Bios-Therapy, Physiological Systems for Health S.p.A
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 150 people enrolled
- Started
- 6 Dec 2022
- Ended
- 10 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Medical Device Iniettabile Ginocchio
- Record updated
- 17 April 2025
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Signed Informed Consent
- Patient of both sexes over 40 years of age
- Diagnosis of primary osteoarthritis of the knee according to the criteria of the American College, radiologically confirmed, i.e., one or more osteophytes and a measurable joint space on a standard radiograph taken within 3 months prior to screening
- Score ≥2 in the target knee on a Likert scale at WOMAC pain question 1 (i.e. pain while walking on a flat surface) at the V-1 screening visit (to be confirmed at the V0 baseline visit). The target knee is defined as the knee with osteoarthritis in the case of unilateral pathology or the only one with this criterion in the case of bilateral pathology
- Severity grade of arthrosis 2 or 3 according to Kellgren \& Lawrence classification
- Be willing to maintain stable eating habits and lifestyle throughout the study period
Who cannot take part
- Intake of analgesics, NSAIDs or opioids within 5 days prior to the start of the run-in (i.e. prior to V-1)
- Cycle of treatment with systemic corticosteroids or intra-articular corticosteroid injection in any joint in the 3 months prior to screening
- Abuse of alcohol, narcotics or psychotropic drugs that can alter the state of vigilance and physical perception
- Previous participation in a clinical study within the last 30 days
- Presence of autoimmune diseases (excluding chronic autoimmune thyroiditis) or other chronic inflammatory processes (e.g. rheumatoid arthritis, ongoing infections, gout)
- Ongoing infections
- Established or presumed allergy to hyaluronic acid, echinacea or centella
- Patients with malignant neoplasms of any kind, or with a history of malignant neoplasms except for patients with a positive history of a malignant neoplasm that has been surgically removed and has not recurred within five years prior to study participation
- Dementia of any kind or other possible causes of progressive deterioration of the mental soundness, or any psychological or physical disability that reduces the ability to take the treatment under study as intended
- Inadequate reliability or presence of conditions that may lead to non- compliance/adherence of the patient to the protocol
- Body Mass Index (BMI) ≥ 30 kg/m2
- Pregnant women
- Intra-articular visco supplementation in the target knee in the preceding 9 months
- Symptomatic arthrosis of the contralateral knee with a score ≥3 on a Likert scale to WOMAC pain question 1 (pain while walking on a flat surface) at V-1 (to be confirmed at V0), or severe symptomatic hip arthrosis
- Significant deformity: genu varum, ligament laxity or meniscus instability
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A pre-market randomized, parallel group, single-blind, clinical study with a Medical Device, made of vegetal material, to evaluate the efficacy and safety of one knee injection of the investigational device versus active comparator (Jonexa). The study population will consist of 150 patients diagnosed with primary knee osteoarthrosis. At present, the study is monocentric competitive.
Read full original descriptionShow less
Treatment period for each patient is 6 months.
The 2 groups in the trial
- Experimental ArmTreatment being tested
Arm: Medical Device Iniettabile Ginocchio
Treatment: Medical Device Iniettabile Ginocchio
- Comparator ArmExisting treatment, for comparison
Arm: Medical Device Jonexa (active comparator medical device from the market )
Treatment: Medical Device Iniettabile Ginocchio
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Parallel Group, Single Blind Clinical Trial Against Active Comparator to Evaluate the Efficacy and Safety of a Medical Device Made of a Vegetal Biological Matrix for the Treatment of Knee Osteoarthritis.
- Record updated
- 17 April 2025